Related Experiment Video
Updated: May 13, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Mobile applications for diabetes self-management: status and potential
Omar El-Gayar1, Prem Timsina, Nevine Nawar
1College of Business and Information Systems, Dakota State University, Madison, South Dakota 57402, USA. Omar.El-Gayar@dsu.edu
Journal of Diabetes Science and Technology
|February 27, 2013
Summary
Mobile applications show promise for diabetes self-management, improving patient attitudes towards managing type 1 and type 2 diabetes. However, usability and integration challenges hinder widespread adoption of these digital health tools.
Area of Science:
- Digital Health
- Mobile Health (mHealth)
- Diabetes Management
Background:
- Smartphone technology and data connectivity have fueled growth in mobile applications for diabetes self-management.
- These applications aim to support individuals with type 1 and type 2 diabetes in managing their condition.
Purpose of the Study:
- To systematically review the effectiveness of diabetes applications in aiding self-management.
- To identify barriers and facilitators for the large-scale adoption of these mobile health interventions.
Main Methods:
- Systematic review of commercial applications from the Apple App Store.
- Inclusion of relevant database articles published between January 1995 and August 2012.
- Focus on applications supporting patient-led diabetes self-management tasks.
Main Results:
- Applications support diverse self-management tasks including exercise, medication, glucose monitoring, and diet.
- Usage is associated with improved patient attitudes towards diabetes self-management.
- Identified limitations include lack of personalized feedback, data entry usability issues, and poor EHR integration.
Conclusions:
- Further research on user-centered design and sociotechnical principles is crucial for improving usability and adoption.
- A holistic approach considering patient expectations and provider needs is essential for effective mobile health interventions in diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...